The objective of this workshop is to share challenges, to detect possible synergies and to learn from each other in order to improve and to facilitate and promulgate high quality ethical clinical research and drug development for these important populations across the whole of the European Union.
The agenda reflects important topics like the special ethical considerations that can affect the informed consent process, evaluation of the safety parameters which is dependent of the adequate reporting of adverse events and interpretation of the adverse drug reactions and proper use of modelling of simulation to bring value to the drug development process.
Drug development is evolving and a lot of effort is constantly done for understanding its particularities in special populations like paediatrics and older people. The two ends of life can be viewed separately, but in the same time they share many common elements like frailty, or vulnerability.
These common aspects were the main components which brought together the Children’s and Geriatric EFGCP Medicines Working Parties in preparing this workshop.
(Tel: +32.2.732 87 83 - Email: conferences@efgcp.eu - Website: www.efgcp.eu)
for articles/videos/studies
This page provides an overview of events related to research and clinical activities organized in Luxembourg.
More information about the event is available by clicking on the event title.
